1-8 of 8
Marita Kloess
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Samira Zeynalova, Eva Lengfelder, M.D., Astrid Franke, M.D., Marcel Reiser, M.D., Hjalmar Steinhauer, M.D., Michael Clemens, M.D., Christina Nickenig, M.D., Maike de Wit, M.D., Bernd Metzner, M.D., Manfred Hensel, M.D., Hans-Guenther Mergenthaler, M.D., Ruediger Liersch, M.D., Ulrich Duehrsen, M.D., Leopold Balleisen, M.D., Monika Engelhardt, M.D., Viola Poeschel, M.D., Joerg Schubert, M.D., Lorenz Truemper, M.D., Norbert Schmitz, M.D., Markus Loeffler, M.D.
Journal: Blood
Blood (2006) 108 (11): 205.
https://doi.org/10.1182/blood.V108.11.205.205
Published: 2006
Journal Articles

Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma

Clinical Trials & Observations
Bertram Glass, Marita Kloess, Martin Bentz, Günter Schlimok, Wolfgang E. Berdel, Alfred Feller, Lorenz Trümper, Markus Loeffler, Michael Pfreundschuh, Norbert Schmitz, for the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Journal: Blood
Blood (2006) 107 (8): 3058–3064.
https://doi.org/10.1182/blood-2005-04-1570
Published: 2006
Journal Articles

Dose Escalated CHOP + Etoposide Followed by Repetitive Autologous Stem Cell Transplantation (MegaCHOEP) with or without Rituximab for Primary Treatment of Aggressive NHL.

Bertram Glass, MD, Marita Kloess, Marcel Reiser, MD, Bernd Metzner, MD, Lorenz H. Truemper, MD, Markus Loeffler, MD, Michael Pfreundschuh, MD, Norbert Schmitz, MD
Journal: Blood
Blood (2005) 106 (11): 1492.
https://doi.org/10.1182/blood.V106.11.1492.1492
Published: 2005
Journal Articles

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Rudolf Schmits, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Hans Steinhauer, MD, Marcel Reiser, MD, Michael Clemens, MD, Christine Nickenig, MD, Martha de Wit, MD, Martin Hoffmann, MD, Roland Mertelsmann, MD, Bernd Metzner, MD, Anthony Ho, MD, Lorenz Truemper, MD, Hans Eimermacher, MD, Hans Mergenthaler, MD, Ruediger Liersch, MD, Ulrich Duehrsen, MD, Leopold Balleisen, MD, Frank Hartmann, MD, Viola Poeschel, MD, Norbert Schmitz, MD, Markus Loeffler, MD
Journal: Blood
Blood (2005) 106 (11): 13.
https://doi.org/10.1182/blood.V106.11.13.13
Published: 2005
Journal Articles

Early Dose Intensity Is Critical in Patients with Aggressive Lymphoma: A Randomized study Comparing Identical Doses of Cyclophosphamide, Adriamycin, Vincristine, Etoposide, and Prednisolone given as 4 or 6 cycles followed by Repetitive Transplantation of Stem Cells (Mega-CHOEP).

Bertram Glass, MD, PhD, Marita Kloess, Marcel Reiser, MD, Wolfgang E. Berdel, MD, PhD, Anthony D. Ho, MD, PhD, Lorenz Truemper, MD, PhD, Marcus Loeffler, MD, PhD, Michael Pfreundschuh, MD, PhD, Norbert Schmitz, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 9.
https://doi.org/10.1182/blood.V104.11.9.9
Published: 2004
Journal Articles

Repetitive High-Dose Therapy with Dose Escalated CHOP + Etoposide Followed by Autologous Stem Cell Transplantation (Mega-CHOEP) in Younger Patients with Primary Diagnosis of Aggressive NHL and Elevated LDH at Diagnosis: Final Analysis.

Norbert Schmitz, MD, PhD, Marita Kloess, Andreas Engert, MD, PhD, Wolfgang E. Berdel, MD, PhD, Bernd Metzner, MD, Lorenz Truemper, MD, PhD, Marcus Loeffler, MD, PhD, Michael Pfreundschuh, MD, PhD, Bertram Glass, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 610.
https://doi.org/10.1182/blood.V104.11.610.610
Published: 2004
Journal Articles

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL

Clinical Trials & Observations
Michael Pfreundschuh, Lorenz Trümper, Marita Kloess, Rudolf Schmits, Alfred C. Feller, Christian Rudolph, Marcel Reiser, Dieter K. Hossfeld, Bernd Metzner, Dirk Hasenclever, Norbert Schmitz, Bertram Glass, Christian Rübe, Markus Loeffler, the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Journal: Blood
Blood (2004) 104 (3): 626–633.
https://doi.org/10.1182/blood-2003-06-2094
Published: 2004
Journal Articles

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Clinical Trials & Observations
Michael Pfreundschuh, Lorenz Trümper, Marita Kloess, Rudolf Schmits, Alfred C. Feller, Christian Rübe, Christian Rudolph, Marcel Reiser, Dieter K. Hossfeld, Hartmut Eimermacher, Dirk Hasenclever, Norbert Schmitz, Markus Loeffler, the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Journal: Blood
Blood (2004) 104 (3): 634–641.
https://doi.org/10.1182/blood-2003-06-2095
Published: 2004